Replies to post #9124 on Calmare Therapeutics Inc (fka CTTC)

[Prudent Capitalist]

Thanks for the excellent info. Powder. I am still long and strong here, and am willing to be patient as things unfold going forward.

[Vaffan-Coulo]

You know it's really pretty sad when someone refers to an ASCO "extended education session" with "What might he talk about?"

After all, after FOUR YEARS working with this miraculous pain killing device, you'd expect him to have his own special session -- wouldn't you?

Then again, if you look at the results he presented at last year's ASCO meeting, it's easy to understand why he hasn't:

http://mascc.ekonnect.co/MASCC_418/poster_37392/program.aspx

What kind of idiotic data presentation is that?

NINE coauthors present the "mean baseline score" and the "worst" baseline score before and after therapy on ELEVEN patients.

They include the standard deviation numbers but don't bother to calculate any p-value.

Although it's obvious from the data that the overlap of the distributions would have likely given a p in the range of .5-.6 -- so FAR AWAY from significance that they likely left it out because reporting it would have drawn howls of laughter.

They then go to the trouble of reporting the per cent changes AND the standard deviation values for those as well -- which is all just a waste of time since the change was INSIGNIFICANT to begin with.

To make things worse, the effect of the therapy was so mediocre compared to what Mr. Marineo gets -- 40-50% versus greater than 90% -- that you have to wonder if they even knew how to operate the machine.

Then again, they probably weren't tuned in to the latest advances in calmare therapy such as including candlelight, soft music, warm blankets, and a "loving environment" like Dr. D'Amato suggests.

Or maybe they just failed to screen for patients "amenable to therapy" like Dr. Cooney recommends.